Medicine and Dentistry
Acute Myeloid Leukemia
100%
Oncogene
72%
CCAAT Enhancer Binding Protein Alpha
66%
Enhancer Region
66%
Leukemia
33%
Resveratrol
33%
Transgene
33%
Drug Sensitivity
33%
Granulocyte Colony Stimulating Factor
33%
Internalization
33%
Amino Acid Substitution
33%
Gain of Function Mutation
33%
Granulocyte
33%
Interleukin 3
33%
Midostaurin
33%
Receptor
33%
Cell Transformation
33%
Disulfide
16%
Microenvironment
16%
In Vitro
16%
Epileptic Absence
16%
Stem Cell Mobilization
16%
Hematologic Malignancy
16%
Cell Surface
16%
Engineered Cell
16%
Dimer
16%
Growth Factor
16%
Cysteine
16%
Helix
16%
Granulopoiesis
16%
Plasmid
16%
Cytokine Receptor
16%
Missense Mutation
16%
Neutrophil
16%
Targeted Therapy
16%
Acute Leukemia
8%
Granulocyte Colony Stimulating Factor Receptor
8%
Transcription Factors
8%
Cooperation
8%
Loss of Function Mutation
8%
NPM1
5%
Cancer
5%
Mitogen-Activated Protein Kinase
5%
Ex Vivo
5%
Induction Chemotherapy
5%
Biological Factor
5%
RNA Sequence
5%
Ras Signaling
5%
DNA Methyltransferase 3A
5%
Keyphrases
Acute Myeloid Leukemia
66%
Leukemia Patients
46%
FLT3 mutation
40%
Stepwise Development
33%
Antioxidant
33%
Gilteritinib
33%
Cancer Chemoprevention
33%
FMS-like Tyrosine Kinase 3 (FLT3)
33%
Genomic Markers
33%
Drug Sensitivity
33%
Brittany
33%
Fanconi Anemia
33%
Midostaurin
33%
Murine Model
33%
Leukemia Microenvironment
33%
Resveratrol
33%
N-acetylcysteine
33%
Tempol
25%
FANCD2
25%
FLT3-ITD
22%
Resistant Cells
20%
Aurora Kinase A (AURKA)
20%
Drug Response Prediction
16%
Chemopreventive
16%
Tumor
16%
Leukemia Cells
13%
Metabolic Reprogramming
13%
Relapsed or Refractory Acute Myeloid Leukemia
12%
CSF2RB
11%
Drive Factors
11%
Identification Validation
11%
Negative Samples
11%
CEBPA mutations
11%
Spleen Colony
8%
Hematologic
8%
Bone Marrow Failure
8%
Quiescence
8%
Blood Cancer
8%
Trp53
8%
Resistance mutations
6%
Cas9 Protein
6%
Proteomics
6%
Cell Culture
6%
Whole Exome Sequencing
6%
Acute Myeloid Leukemia Cells
6%
Metabolomics
6%
Intrinsic Mechanism
6%
Resistance Mechanisms
6%
Subclone
6%
Bone Marrow Microenvironment
6%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Internalization
33%
Enhancer Region
33%
Proteogenomics
33%
Gain of Function Mutation
33%
Dimerization
33%
Oncogene
33%
CCAAT Enhancer Binding Protein Alpha
33%
Granulocyte
33%
Cell Transformation
33%
Drug Response
33%
Amino Acid Substitution
33%
Eicosanoid Receptor
33%
Interleukin 3
33%
Granulocyte Colony-Stimulating Factor
33%
Drug Sensitivity
22%
Transcriptomics
22%
Genetics
22%
Aurora B Kinase
20%
Proteomics
17%
CSF2RB
16%
STAT5
16%
Plasmid
16%
Cysteine
16%
Granulopoiesis
16%
STAT3
16%
Missense Mutation
16%
Surface Property
16%
Transmembrane Domain
16%
Hematopoietic Stem Cell
16%
Disulfide
16%
Reprogramming
13%
Phosphoproteomics
11%
Proteome
11%
Loss of Function Mutation
6%
CRISPR/Cas9
6%
Transcription Factors
6%
Exome Sequencing
6%
Cooperation
6%
Metabolomics
6%
Cell Culture
6%
Granulocyte Colony-Stimulating Factor Receptor
6%
